Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind vehicle-controlled study of DRM04 (glycopyrronium) wipes in primary axillary hyperhidrosis
2015-002052-27Phase 3Completed
- Sponsor
- Dermira, Inc.
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in essential axillary hyperhidrosis comparing DRM04 glycopyrronium 3.75% topical wipes with Vehicle topical wipes (2 arms). Primary endpoint: Mean absolute change in sweat production at Week 4. Started Aug 2015; status: completed.
02
Drugs
glycopyrronium
03
Conditions
essential axillary hyperhidrosis
Beyond the preview
Go deeper on 2015-002052-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002052-27.